Vijay Iyengar, M.D.
About Vijay Iyengar, M.D.
Vijay Iyengar, M.D., is the Executive Vice President of Global Medical Affairs, Product, and Partnership Strategy, with a strong background in both U.S. and global healthcare leadership roles.
Vijay Iyengar Executive Vice President
Vijay Iyengar, M.D., currently serves as the Executive Vice President of Global Medical Affairs, Product, and Partnership Strategy. In this role, he oversees the strategic direction and execution of medical affairs initiatives, product development, and partnership engagements on a global scale. His broad expertise and leadership play a crucial role in advancing the organization's objectives and fostering collaborations that drive innovation in healthcare.
Vijay Iyengar Education and Expertise
Vijay Iyengar holds a Bachelor of Science degree in Biology from Stanford University. He further advanced his education by earning a Doctor of Medicine (M.D.) degree from Harvard Medical School. His academic background provides a solid foundation in biological sciences and clinical medicine, which informs his strategic decisions and leadership approach within the healthcare industry.
Vijay Iyengar Professional Background
Vijay Iyengar has a comprehensive background in the healthcare sector, demonstrated by his previous roles in major pharmaceutical companies. He served as President of Genoptix Corporation, a Novartis Company, where he managed cancer diagnostic services. His tenure at Novartis includes multiple leadership positions such as Vice President and Rare Diseases Franchise Head at Novartis Oncology and Oncology General Manager of Novartis Greece, where he played key roles in organizational leadership and market strategy.
Vijay Iyengar at McKinsey & Company
Earlier in his career, Vijay Iyengar was an Engagement Manager at McKinsey & Company. In this capacity, he worked within their healthcare practice, advising pharmaceutical and medical device clients. His role involved developing strategic solutions to complex challenges faced by these clients, leveraging his medical and business acumen to drive performance improvements and innovation.